Shanghai Pharmaceuticals Holding Co. Ltd. at its AGM held on 29 June 2023 announced that Mr. DONG Ming was duly elected by the shareholders of the Company as executive Director of the eighth session of the Board, Mr. YAO Jiayong and Mr. CHEN Fashu were duly elected by the shareholders of the Company as non-executive Directors of the eighth session of the Board, Mr. WANG Zhong were duly elected by the shareholders of the Company as independent non-executive Directors of the eighth session of the Board, Mr. MA Jia were duly elected by the shareholders of the Company as supervisor of the eighth session of the board of supervisors of the Company, all with effect from 29 June 2023. Mr. YU Weidong was duly elected as an employee representative Supervisor of the eighth session of the Board of Supervisors by the employees' representatives conference of the Company, with his term revised to take effect from 29 June 2023.

Each of Mr. GE Dawei, Mr. CHO Man, Ms. LI An, Mr. CAI Jiangnan and Mr. HONG Liang ceased to act as a Director, Mr. HUAN Jianchun ceased to act as an employee representative Supervisor and Mr. XIN Keng ceased to act as a Supervisor due to the expiry of each of their terms of office as a Director or Supervisor, with effect from 29 June 2023. Mr. ZHOU Jun, a non-executive Director, has been elected by the Board as the chairman of the eighth session of the Board for a term of three years and Mr. YAO Jiayong, a non-executive Director, has been elected by the Board as the vice chairman of the eighth session of the Board for a term for three years, both with effect from 29 June 2023; Mr. XU Youli, a Supervisor, has been elected by the Board of Supervisors as the chief Supervisor of the eighth session of the Board of Supervisors for a term of three years, with effect from 29 June 2023; Mr. ZHOU Jun, a non-executive Director, has been elected by the Board as the convener of the Strategy Committee of the Board; Mr. CHEN Fashu, a non-executive Director, and Mr. WANG Zhong, an independent non-executive Director, have been elected by the Board as members of the Strategy Committee of the Board; Mr. Manson FOK, an independent non-executive Director, has been elected by the Board as the convener of the Nomination Committee of the Board; Mr. SHEN Bo, an executive Director, and Mr. GU Zhaoyang, an independent non-executive Director, have been elected by the Board as members of the Nomination Committee of the Board; Mr. GU Zhaoyang, an independent non-executive Director, has been elected by the Board as the convener of the Audit Committee of the Board; Mr. Manson FOK, an independent non-executive Director, and Mr. WANG Zhong, an independent non-executive Director, have been elected by the Board as members of the Audit Committee of the Board; Mr. WANG Zhong, an independent non-executive Director, has been elected by the Board as the convener of the Remuneration and Assessment Committee of the Board; Mr. YAO Jiayong, a non-executive Director, and Mr. GU Zhaoyang, an independent non-executive Director, have been elected by the Board as members of the Remuneration and Assessment Committee of the Board.